This is a medication used to treat HIV. It helps stop the virus from multiplying in your body.
Every report comes from a Lived member, sent anonymously.
Have you tried Reyataz (Atazanavir) for HIV Infection?
Atazanavir, sold as Reyataz and as generic capsules, is a prescription medicine for HIV-1, the most common type of HIV (human immunodeficiency virus). It is used in adults and in children at least 3 months old who weigh at least 5 kilograms (about 11 pounds), and it is never used on its own: it is one part of a combination of HIV medicines taken together every day, an approach called antiretroviral therapy. It is not given to babies younger than 3 months because of the risk of dangerous jaundice. Atazanavir belongs to a group called protease inhibitors. It is often paired with a booster, either ritonavir (another HIV medicine given in a small dose) or cobicistat (a boosting agent with no HIV activity of its own). Evotaz is a single tablet that combines atazanavir with cobicistat, for adults and for children weighing at least 35 kilograms. Atazanavir does not cure HIV, but keeping the virus under control protects the immune system and lowers the chance of HIV-related illness. Current European treatment guidelines list newer first-choice regimens built on medicines such as dolutegravir or bictegravir (integrase inhibitors), so atazanavir is more often an option chosen for a particular person's history, resistance pattern or other medicines than a default starting drug.
HIV makes copies of itself inside the body's immune cells. To build a new working virus, it first produces long chains of proteins that an enzyme called protease must cut into smaller pieces. Atazanavir blocks this enzyme, so the new virus particles stay immature and cannot go on to infect other cells. Over weeks, this lowers the amount of virus in the blood, called the viral load, and gives the immune system a chance to recover. A booster such as ritonavir or cobicistat has no meaningful effect on HIV at the dose used. Instead it slows the liver's breakdown of atazanavir, keeping its level in the blood higher and steadier. The same slowing effect is why boosted atazanavir interacts with so many other medicines.
Atazanavir is taken once a day, and it must be taken with food, which helps the body absorb it. Capsules are swallowed whole and should not be opened. For adults starting HIV treatment for the first time, the usual choices are 300 mg together with ritonavir 100 mg, or in some cases 400 mg without a booster. People who have taken HIV medicines before, or whose earlier treatment stopped working, take it with a booster. Evotaz combines the medicine and its booster in one tablet. Children's doses are based on weight. Reyataz oral powder, for young children and for anyone who cannot swallow capsules, is mixed with soft food such as applesauce or yogurt, or with infant formula given by oral syringe, and is always followed by ritonavir. The powder contains phenylalanine, which matters for people with phenylketonuria (PKU). Blood and urine tests of kidney function are done before starting and during treatment, and liver tests are added for people with liver disease. If a dose is missed, take it as soon as possible and return to the usual schedule, but do not double the next dose. Taking every dose matters: when levels of HIV medicines drop, the virus can become resistant to them.
The most noticeable side effect is yellowing of the skin or the whites of the eyes. Atazanavir raises bilirubin, a yellow pigment the liver normally clears. In most people this rise causes no harm and reverses if the medicine is stopped, but yellowing should still be mentioned to the care team, which can check that the liver is otherwise fine and discuss switching if the color is bothersome. Nausea, headache, stomach pain, diarrhea, trouble sleeping, tingling in the hands or feet, muscle aches and dizziness can also occur. Rash affects about one in five people, often appearing around the second month. It is mostly mild and often clears within a week or two while treatment continues. Rarely, a rash is severe, such as Stevens-Johnson syndrome. A rash that spreads, blisters or peels, or that comes with fever, mouth sores or sore red eyes, means stopping the medicine and getting medical care right away. Atazanavir has been linked to kidney stones, gallstones and, over time, chronic kidney disease. Drinking enough fluids helps. Sudden pain in the side, back or lower abdomen, blood in the urine, or pain in the upper right abdomen should be reported promptly. It can also slow the heart's electrical signal, so dizziness or lightheadedness is worth telling the care team about.
Medicines that lower stomach acid can stop atazanavir from working. It needs an acidic stomach to dissolve, so heartburn medicines reduce how much reaches the blood, which can let the virus rebound and become resistant. Proton pump inhibitors such as omeprazole (Prilosec) are not recommended for people who have taken HIV medicines before or who take atazanavir without a booster. For adults starting treatment on atazanavir boosted with ritonavir, only a low dose taken about 12 hours before atazanavir is allowed. H2 blockers (histamine-2 blockers) such as famotidine (Pepcid) need timed doses, and antacids such as Tums are taken at least 2 hours after or 1 hour before atazanavir. Check with the prescriber or pharmacist before using any heartburn product, including over-the-counter ones. Atazanavir, especially when boosted, raises or lowers the levels of many other medicines. Some combinations must be avoided entirely, including the herbal supplement St. John's wort, the tuberculosis antibiotic rifampin, the seizure medicines carbamazepine, phenytoin and phenobarbital, the cholesterol medicines simvastatin and lovastatin, and some hepatitis C treatments. Others need dose changes or closer monitoring, including some blood thinners, erectile dysfunction medicines, inhaled steroids such as fluticasone, and other hepatitis C treatments. Hormonal birth control pills may need a specific estrogen dose, and for patches, rings and injections the combination has not been studied, so another contraceptive method is usually advised. Keep an up-to-date list of every prescription, over-the-counter medicine and supplement, and share it before anything new is started. People with hepatitis B or C, existing kidney disease or kidney stones, heart rhythm problems, diabetes or hemophilia need extra caution and monitoring. During pregnancy atazanavir is taken with ritonavir, not with cobicistat, because cobicistat-boosted levels fall too low later in pregnancy. Anyone who becomes pregnant while taking Evotaz should talk to their prescriber promptly about switching. Available data do not show an increase in major birth defects, and newborns exposed before birth are checked for jaundice in the first days of life.
Like other HIV regimens, atazanavir works gradually: viral load usually falls over the first weeks to months, and blood tests track that response along with kidney function and, for some people, liver function. Rash, if it appears, often starts within the first couple of months. Yellowing from raised bilirubin is common and goes away if the medicine is stopped. HIV treatment is long term. Stopping or skipping doses lets the virus multiply again and can lead to resistance that limits future choices, so changes, including switching to another regimen, are made with the prescriber rather than by stopping. If yellowing, kidney concerns or interactions with other medicines become a problem, switching to a different regimen is a common discussion.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Reyataz (Atazanavir), what you've noticed, or ask the community a question.